Cylert

Lea en español

CylertCylert is the brand name for Pemoline, a stimulant first synthesized in 1913 and used to treat ADHD (attention deficit hyperactivity disorder) and narcolepsy. Pemoline has been pulled from the U.S. market because of reports connecting its use in children to increased risk of liver failure. After the U.S. Food and Drug Administration (FDA) issued a warning not to prescribe Pemoline for ADHD, the manufacturer and patent owner (Abbott Laboratories) stopped making Cylert.

Pemoline was first approved by the FDA in 1975. Since that date, more than 20 liver failures have been linked to the drug. Pemoline is believed to cause hepatoxicity, a chemically induced form of liver damage.

If you or someone you love has used any type of Cylert and experienced detrimental side effects, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

Defective Drugs & Medical Devices Topics

Latest Articles

The 25th Amendment to the United States Constitution Is in the News

The Constitutional Process for Replacing a President Who Lacks Capacity to Serve The United States C…

15 Oct 2020, Thursday

The Legal Consequences of Voting Twice

Why You Shouldn’t Follow Trump’s Suggestion to “Test Integrity of Electoral System” | P…

21 Sep 2020, Monday

Medical Malpractice: How It Differs from Other Negligence Claims

The Standard of Care – What You Must Prove to Recover for Your Losses When you’re hurt in an…

21 Aug 2020, Friday